Multi-institutional phase 2 study of TLK286 (TELCYTA, a glutathione S-transferase P1-1 activated glutathione analog prodrug) in patients with platinum and paclitaxel refractory or resistant ovarian cancer
(Q46598239)
scientific article published in July 2005
scientific article published in July 2005
Language:
other details
| description | scientific article published in July 2005 |
External Links
| (P356) |
10.1111/J.1525-1438.2005.00114.X
|
| (P698) |
16014111
|